# Middle Meningeal Artery Embolization for Chronic Subdural Hematoma

> **NCT04065113** · — · WITHDRAWN · sponsor: **Washington University School of Medicine**

## Conditions studied

- Chronic Subdural Hematoma

## Interventions

- **PROCEDURE:** Middle Meningeal Artery Embolization with polyvinyl alcohol particles (PVA)
- **PROCEDURE:** Drainage of Subdural Hematoma

## Key facts

- **NCT ID:** NCT04065113
- **Lead sponsor:** Washington University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** WITHDRAWN
- **Start date:** 2019-09-19
- **Primary completion:** 2024-08-01
- **Final completion:** 2025-06-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** due to reason 3 in the protocol- any new information becomes available during the trial that necessitates stopping the trial. New information became available with device no longer being investigational.
- **Last updated:** 2025-07-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04065113

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04065113, "Middle Meningeal Artery Embolization for Chronic Subdural Hematoma". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT04065113. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*